Test ID LPSC Lipid Panel, Fasting, Serum
Reporting Name
Lipid Panel, FastingUseful For
Evaluation of cardiovascular risk
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CHOL | Cholesterol, Total, S | Yes | Yes |
TRIG | Triglycerides, S | Yes | Yes |
HDCH | Cholesterol, HDL, S | Yes | Yes |
CLDL | Calculated LDL | No | Yes |
NHDCH | Non HDL Cholesterol | No | Yes |
Specimen Type
SerumSpecimen Required
Patient Preparation:
1. Fasting overnight (12 hours)
2. Patient must not consume any alcohol for 24 hours before the specimen is drawn.
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 1 mL
Collection Instructions:
1. Serum gel tube must be centrifuged within 2 hours of draw time.
2. Red-top tube must be centrifuged and aliquoted within 2 hours of draw time.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 30 days |
Reference Values
The National Lipid Association and the National Cholesterol Education Program (NCEP) have set the following guidelines for lipids (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, and non-HDL cholesterol) in adults ages 18 and up:
TOTAL CHOLESTEROL
Desirable: <200 mg/dL
Borderline high: 200-239 mg/dL
High: ≥240 mg/dL
TRIGLYCERIDES
Normal: <150 mg/dL
Borderline high: 150-199 mg/dL
High: 200-499 mg/dL
Very high: ≥500 mg/dL
HDL CHOLESTEROL
Males
≥40 mg/dL
Females
≥50 mg/dL
LDL CHOLESTEROL
Desirable: <100 mg/dL
Above desirable: 100-129 mg/dL
Borderline high: 130-159 mg/dL
High: 160-189 mg/dL
Very high: ≥190 mg/dL
NON-HDL CHOLESTEROL
Desirable: <130 mg/dL
Above desirable: 130-159 mg/dL
Borderline high: 160-189 mg/dL
High: 190-219
Very high: ≥220 mg/dL
The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents has set the following guidelines for lipids (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, and non-HDL cholesterol) in children ages 2-17:
TOTAL CHOLESTEROL
Acceptable: <170 mg/dL
Borderline high: 170-199 mg/dL
High: ≥200 mg/dL
TRIGLYCERIDES
2-9 years:
Acceptable: <75 mg/dL
Borderline high: 75-99 mg/dL
High: ≥100mg/dL
10-17 years:
Acceptable: <90 mg/dL
Borderline high: 90-129 mg/dL
High: ≥130 mg/dL
HDL CHOLESTEROL
Low HDL: <40 mg/dL
Borderline low: 40-45 mg/dL
Acceptable: >45 mg/dL
LDL CHOLESTEROL
Acceptable: <110 mg/dL
Borderline high: 110-129 mg/dL
High: ≥130 mg/dL
NON-HDL CHOLESTEROL
Acceptable: <120 mg/dL
Borderline high: 120-144 mg/dL
High: ≥145 mg/dL
Day(s) and Time(s) Performed
Calculated LDL: Monday through Saturday; Continuously
Cholesterol, HDL: Monday through Sunday; Continuously
Triglycerides: Monday through Sunday; Continuously
Cholesterol, Total: Monday through Sunday; Continuously
Non HDL Cholesterol: Monday through Saturday; Continuously
CPT Code Information
80061-Lipid panel (if all 3 performed)
82465-Cholesterol, total (if all 3 are not performed)
84478-Triglycerides (if all 3 are not performed)
83718-Cholesterol, HDL (if all 3 are not performed)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LPSC | Lipid Panel, Fasting | 24331-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CHOL | Cholesterol, Total, S | 2093-3 |
CLDL | Calculated LDL | 13457-7 |
HDCH | Cholesterol, HDL, S | 2085-9 |
NHDCH | Non HDL Cholesterol | 43396-1 |
TRIG | Triglycerides, S | 2571-8 |
Clinical Information
Cardiovascular disease is the number one cause of death in the United States with an estimated 1.5 million heart attacks and 0.5 million strokes occurring annually, many in individuals who have no prior symptoms. Prevention of ischemic cardiovascular events is key. Risk factors including age, smoking status, hypertension, diabetes, cholesterol, and HDL cholesterol, are used by physicians to identify individuals likely to have an ischemic event.
Interpretation
Mayo Clinic has adopted the National Lipid Association classifications, which are included as reference values on Mayo Clinic and Mayo Clinic Laboratories reports (see Reference Values). Lipids are most commonly measured to assess cardiovascular risk. Maintaining desirable concentrations of lipids lowers the risk of heart attacks or strokes. Establishing appropriate treatment strategies and lipid goals require the results for each component of a lipid profile be considered in context with other risk factors including, age, sex, smoking status, family and personal history of heart disease.
Clinical Reference
1. Jacobson TA, Ito MK, Maki KC, et al: National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol 2014 Sep-Oct;8(5):473-488
2. Goff DC, Lloyd-Jones DM, Gennett G, et al: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation 2014;129:S49-S73
3. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. Pediatrics 2011;128;S213-S256
Analytic Time
1 dayMethod Name
CHOL, TRIG, HDCH: Enzymatic Colorimetric
CLDL: Friedewald Equation
NHDCH: Total Cholesterol-HDL Cholesterol